The Biden administration is gearing up for a fall vaccination campaign that not only includes updated COVID-19 boosters, but the annual flu shot and the newly approved RSV vaccine.

The Justice Department announced Wednesday the results of a coordinated, nationwide enforcement action to combat COVID-19 fraud, which included 718 enforcement actions – including federal criminal charges against 371 defendants – for offenses related to over $836 million in alleged COVID-19 fraud.

The Biden administration on Tuesday announced a $1.4 billion investment in developing the so-called next generation of COVID-19 vaccines and treatments.

Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) is investigating whether an unlicensed lab in California owned by Prestige Biotech, a Chinese company, posed a threat to public health for allegedly conducting dangerous research related to COVID-19.

The Government Accountability Office (GAO) recently released a new report on the agency’s key findings and recommendations with an eye toward helping federal agencies be better prepared for future emergencies.

Nutritional supplement company Quickwork LLC and one of its managers, Eric Anthony Nepute, have agreed to injunctions and to pay civil penalties to resolve a lawsuit alleging they deceptively marketed vitamin supplements during the COVID-19 pandemic, in violation of the Federal Trade Commission Act and the COVID-19 Consumer Protection Act.

Nearly 1 in 5 children and teens diagnosed with SARS-CoV-2 showed one or more persistent symptoms three months after the infection, according to a review article published in the August 2023 Pediatrics.

Ohio Department of Health (ODH) Director Bruce Vanderhoff, MD, MBA Thursday said he is confident that the COVID-19 vaccine will continue to be readily available to Ohioans, including to those without insurance, even as the vaccine supply next week begins to transition to a more traditional healthcare model.

A U.S. Senate committee approved legislation Thursday that would update how the federal government prepares for and then responds to pandemics and natural disasters.

The U.S. Food and Drug Administration recently approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.

After more than three years and 1.1 million deaths, the United States on Thursday will end the public health emergency for COVID-19 — and Congress is attempting to better prepare for a possible resurgence of that virus or another.

Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from additional COVID-19 vaccine doses.

After Congress ended pandemic food assistance in February, 70,000 older Ohioans have seen food benefits slashed to $23 a month, in some cases down from $280.

The U.S. director of national intelligence has three months to declassify information on potential links between China’s Wuhan Institute of Virology and the origin of COVID-19, after President Joe Biden signed legislation Monday.